IP Library Granted Patent US 12,275,724
Granted Patent B2
US 12,275,724 · App. 18/671,182 · Granted Apr 15, 2025

Processes and intermediates for the preparation of soluble guanylate cyclase stimulators

Inventors: Debra Jane Wallace (Lexington, MA); Fenger Zhou (Cambridge, MA); Yuguang Wang (Cambridge, MA); Takashi Nakai (Newton, MA); Vishnu Vardhan Reddy Karnati (Sudbury, MA); Wayne C. Schairer (Westboro, MA); William Kissel (Cambridge, MA); Song Xue (Newton, MA); Ahmad Hashash (Southborough, MA)
Assignee: Cyclerion Therapeutics, Inc.
C07D413/14C07D403/04C07D413/12C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,275,724
App. No.
18/671,182
Granted
Apr 15, 2025
Kind
B2
Abstract

The present disclosure relates to novel processes for the preparation of compounds of Formula I. Some of these compounds are useful as stimulators of soluble guanylate cyclase (sGC). Others are useful intermediates towards the preparation of said stimulators. These processes are amenable to large scale preparation and produce stable 3-(2-pyrimidinyl) pyrazoles of Formula I in high purity and yields. The present invention has the additional advantage of facile reaction conditions, amenable to scale up for large scale manufacturing. The disclosure also provides novel intermediates useful in the preparation of said compounds.

Claims (5)

1. A compound of formula (3) or (4):

wherein R 1 is phenyl, or a 5 to 6-membered heteroaryl ring; optionally substituted with up to three instances independently selected from the group consisting of halogen or methyl; wherein said 5 or 6-membered heteroaryl ring contains up to 3 ring atoms selected from the group consisting of N, S or O.

2. The compound of claim 1 , wherein R 1 is a 5-membered heteroaryl ring.

3. The compound of claim 2 , wherein R 1 is an unsubstituted 5-membered heteroaryl ring containing up to 2 ring heteroatoms selected from the group consisting of N and O.

4. The compound of claim 3 , wherein the compound is represented by formula (3′) or (4′):

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2024
From: WALLACE, DEBRA JANE; ZHOU, FENGER; WANG, YUGUANG; NAKAI, TAKASHI; KARNATI, VISHNU VARDHAN REDDY; SCHAIRER, WAYNE C.; KISSEL, WILLIAM; XUE, SONG; HASHASH, AHMAD
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 068648/0032 →
Priority Claims (1)
WO PCT/CN2018/076982 · Feb 22, 2018 · international
Continuity (5)
Division 18140966 · Apr 28, 2023
Division 17497352 · Oct 8, 2021
Division 16961109
Provisional Application 62615678 · Jan 10, 2018
Related Publication 20240391911A1 · Nov 28, 2024
References Cited (19)
US 9481689B2 · Nakai et al. · 2016 [cited by applicant]
US 10183021B2 · Nakai et al. · 2019 [cited by applicant]
US 11274096B2 · Wallace et al. · 2022 [cited by applicant]
US 11708361B2 · Wallace et al. · 2023 [cited by applicant]
US 11834444B2 · Xue et al. · 2023 [cited by applicant]
US 12030874B2 · Wallace et al. · 2024 [cited by applicant]
US 20160324856A1 · Long et al. · 2016 [cited by applicant]
US 20170137439A1 · Nakai et al. · 2017 [cited by applicant]
US 20170291889A1 · Barden · 2017 [cited by examiner]
US 20210323951A1 · Xue et al. · 2021 [cited by applicant]
WO 2012003405A1 · 2012 [cited by applicant]
WO 2016044441A1 · 2016 [cited by applicant]
WO 2016044447A1 · 2016 [cited by applicant]
WO 2017095697A1 · 2017 [cited by applicant]
U.S. Appl. No. 16/961,109, filed Jul. 9, 2020, U.S. Pat. No. 11,274,096, Issued. [cited by applicant]
U.S. Appl. No. 17/497,352, filed Oct. 8, 2021, U.S. Pat. No. 11,708,361, Issued. [cited by applicant]
U.S. Appl. No. 18/140,966, filed Apr. 28, 2023, U.S. Pat. No. 12,030,874, Issued. [cited by applicant]
Nakai et al., Discovery of IWP-051, a Novel Orally Bioavailable sGC Stimulator with Once-Daily Dosing Potential in Humans. ACS Med Chem Lett. Feb. 24, 2016;7(5):465-9. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2019/013060, dated Apr. 11, 2019, 10 pages. [cited by applicant]